ResearchPod Summary
Chronic cocaine abuse is strongly associated with the exacerbation of HIV-1 associated neurological disorders (HAND). While extracellular vesicles (EVs) are known to mediate intercellular communication and have been implicated in the pathogenesis of various syndromes, their specific roles in how cocaine influences HIV-1 persistence and neuroinflammation remain poorly understood. This study investigates how cocaine alters the biogenesis, molecular composition, and inflammatory potential of EVs released by HIV-1 infected immune cells.
The researchers examined T-cells, dendritic cells (DCs), and macrophages infected with HIV-1 in the presence or absence of cocaine. They used ultracentrifugation and immune-affinity techniques to isolate and purify EVs. Key experimental methods included:
Cocaine significantly augmented the release of EVs from HIV-1 infected DCs and macrophages compared to untreated controls. These cocaine-modulated EVs carried higher levels of viral genes (such as GAG and RRE), which facilitated enhanced HIV-1 trans-infection of T-cells. The researchers discovered that DCs and macrophages express higher levels of the cocaine receptor Sigma 1-Receptor, making them more sensitive to the drug. Mechanistically, cocaine treatment downregulated the expression of the restriction factor BST-2, which normally tethers viral particles and EVs to the cell surface. This downregulation allowed for altered intracellular trafficking of virus-containing vesicles toward an exosomal pathway, leading to increased release of EVs containing viral components. Furthermore, these EVs were shown to compromise the barrier integrity of HBMECs and induce the release of pro-inflammatory cytokines, providing a direct link to the neuroinflammation observed in clinical settings.
AI-generated third-party summary by ResearchPod. Not official content or an endorsement by the paper authors or affiliated organizations.